
SBRA
Sabra Health Care REIT Inc.
$18.49
-$0.22(-1.18%)
92
Overall
95
Value
90
Tech
--
Quality
Market Cap
$4.49B
Volume
1.92M
52W Range
$15.60 - $20.03
Target Price
$21.18
Order:
Income Statement
Metric | Trend | Chart | 2015 Dec | 2016 Dec | 2017 Dec | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
---|---|---|---|---|---|---|---|---|---|---|---|---|
REVENUE | ||||||||||||
Total Revenue | $238.9M | $233.1M | $390.6M | $606.7M | $580.2M | $586.6M | $552.2M | $587.3M | $612.4M | $666.1M | ||
Total Revenue | $238.9M | $260.5M | $26.4M | $70.1M | $661.7M | $598.6M | $569.5M | $624.8M | $647.5M | $703.2M | ||
COST OF GOODS SOLD | ||||||||||||
Cost of Revenue | $-3.7M | $-1.0M | $-7.0M | $-27.7M | -- | $131.6M | $141.2M | $162.6M | $195.2M | -- | ||
GROSS PROFIT | ||||||||||||
Gross Profit | $238.9M | $233.1M | $390.6M | $606.7M | $661.7M | $467.0M | $428.3M | $462.2M | $647.5M | $703.2M | ||
OPERATING EXPENSES | ||||||||||||
Operating Expenses | $-2.6M | $-5.7M | $-17.9M | $-49.5M | $86.3M | $111.0M | $121.0M | $227.5M | $228.2M | $216.4M | ||
Selling, General & Administrative | $23.9M | $17.7M | $32.4M | $36.5M | $32.1M | $34.6M | $38.6M | $39.7M | $47.7M | $49.5M | ||
General & Administrative Expenses | $23.9M | $17.7M | $32.4M | $36.5M | $32.1M | $34.6M | $38.6M | $39.7M | $47.7M | $49.5M | ||
Salaries & Wages | $2.6M | $5.7M | $17.9M | $49.5M | $9.8M | $7.9M | $7.9M | -- | -- | -- | ||
Depreciation & Amortization | $63.1M | $68.5M | $113.9M | $191.4M | $181.5M | $176.7M | $179.0M | $187.8M | $183.1M | $169.6M | ||
Depreciation & Amortization | $63.1M | $68.5M | $113.9M | $191.4M | $181.5M | $176.7M | $179.0M | $187.8M | $183.1M | $169.6M | ||
Amortization | $-5.1M | $-5.7M | $-7.8M | $-10.1M | $10.1M | $9.8M | $22.2M | $11.0M | $5.8M | $2.6M | ||
Other Operating Expenses | $10.6M | $-5.1M | $13.9M | $34.6M | $106.4M | $129.4M | $140.8M | $1.1M | $-2.6M | $-2.7M | ||
OPERATING INCOME | ||||||||||||
Operating income | $138.8M | $146.3M | $212.5M | $294.8M | $260.1M | $245.9M | $193.8M | $358.7M | $384.3M | $449.7M | ||
EBITDA | $207.7M | $210.3M | $368.2M | $636.1M | $397.5M | $416.3M | $166.2M | $416.8M | $311.8M | $430.6M | ||
NON-OPERATING ITEMS | ||||||||||||
Interest Expense (Non-Operating) | $59.2M | $64.9M | $88.4M | $147.1M | $126.6M | $100.4M | $98.6M | $105.5M | $113.0M | $115.3M | ||
Interest Income Operating | $-161.0K | $27.5M | $15.0M | $16.7M | $81.5M | $11.9M | $17.3M | $37.6M | $35.1M | $37.2M | ||
Intinc | -- | -- | -- | $128.2M | -- | -- | -- | -- | -- | -- | ||
Net Non-Operating Interest Income/Expense | $-59.2M | $-64.9M | $-88.4M | $-147.1M | $-126.6M | $-100.4M | $-98.6M | $-105.5M | $-113.0M | $-115.3M | ||
Gain on Sale of Securities | -- | $7.2M | $12.9M | $2.8M | $377.0K | $27.0K | -- | -- | -- | -- | ||
Other Income/Expense | $161.0K | $37.7M | $32.1M | $-117.8M | $142.7M | $1.7M | $31.8M | $-205.6M | $92.5M | $16.4M | ||
Other Special Charges | -- | $-556.0K | $-553.0K | $-2.9M | $-16.3M | $-531.0K | $-34.6M | $-411.0K | $-1.5M | -- | ||
SPECIAL ITEMS | ||||||||||||
Restructring And Mn A Income | $-12.8M | $-7.3M | $-2.7M | $-5.3M | -- | -- | -- | -- | -- | -- | ||
Special Income Charges | $12.8M | $7.3M | $52.0M | $5.3M | $2.3M | -- | -- | -- | -- | $500.0K | ||
Other Impairment Of Capital Assets | -- | $29.8M | $1.3M | $1.4M | $121.8M | $4.0M | $9.5M | $94.0M | $14.3M | $18.5M | ||
PRE-TAX INCOME | ||||||||||||
EBIT | $139.3M | $136.1M | $247.5M | $434.7M | $205.8M | $239.6M | $-12.8M | $217.9M | $128.7M | $250.5M | ||
Pre-Tax Income | $80.1M | $71.3M | $159.0M | $287.6M | $79.2M | $155.7M | $80.7M | $-76.4M | $18.7M | $128.1M | ||
INCOME TAX | ||||||||||||
Tax Provision | -- | $1.0M | $651.0K | $3.0M | $3.4M | $710.0K | $1.8M | $1.2M | $2.0M | $1.0M | ||
NET INCOME | ||||||||||||
Net Income | $79.4M | $70.3M | $158.4M | $279.1M | $69.0M | $138.4M | $-113.3M | $-77.6M | $13.8M | $126.7M | ||
Net Income (Continuing Operations) | $79.4M | $70.3M | $158.4M | $279.1M | $69.0M | $138.4M | $-113.3M | $111.2M | $13.8M | $134.2M | ||
Net Income (Discontinued Operations) | $79.4M | $70.3M | $158.4M | $279.1M | $69.0M | $138.4M | $-113.3M | $-77.6M | $13.8M | $126.7M | ||
Net Income (Common Stockholders) | $69.2M | $60.0M | $148.2M | $269.3M | $69.0M | $138.4M | $-113.3M | $-77.6M | $13.8M | $126.7M | ||
Normalized Income | -- | -- | -- | -- | -- | -- | -- | -- | -- | $143.2M | ||
TOTALS | ||||||||||||
Total Expenses | $-6.3M | $-6.7M | $-24.8M | $-27.7M | $86.3M | $111.0M | $121.0M | $390.1M | $228.2M | $216.4M | ||
SHARE & EPS DATA | ||||||||||||
Average Shares Outstanding | $62.2M | $65.3M | $105.6M | $178.3M | $187.2M | $206.2M | $219.1M | $230.9M | $231.2M | $233.5M | ||
Average Shares Outstanding (Diluted) | $62.5M | $65.5M | $105.8M | $178.7M | $188.1M | $207.3M | $219.1M | $230.9M | $232.8M | $236.0M | ||
Shares Outstanding | $130.4M | $130.6M | $356.5M | $356.6M | $410.5M | $210.7M | $230.9M | $231.2M | $231.5M | $237.9M | ||
Basic EPS | $1.11 | $0.92 | $1.4 | $1.51 | $0.37 | $0.67 | $-0.52 | $-0.34 | $0.06 | $0.54 | ||
Basic EPS (Continuing Operations) | -- | -- | -- | -- | $0.37 | $0.67 | $-0.52 | $-0.34 | $0.06 | $0.54 | ||
Diluted EPS | $1.11 | $0.92 | $1.4 | $1.51 | $0.37 | $0.67 | $-0.52 | $-0.34 | $0.06 | $0.54 | ||
Diluted EPS (Continuing Operations) | -- | -- | -- | -- | $0.37 | $0.67 | $-0.52 | $-0.34 | $0.06 | $0.54 | ||
Dividend Per Share | $1.6 | $1.67 | $1.73 | $1.8 | $1.8 | $1.35 | $1.2 | $1.2 | $1.2 | $1.2 | ||
OTHER METRICS | ||||||||||||
Accrued Preferred Stock Dividends | $10.2M | $10.2M | $10.2M | $9.8M | -- | -- | -- | -- | -- | -- | ||
Acquired In Process Rn D | -- | -- | $52.0M | -- | $2.3M | -- | -- | -- | -- | -- | ||
Acquired In Process Rn D Income | -- | -- | -- | -- | -- | -- | -- | -- | $-76.6M | $2.1M | ||
Acquisition Expense | -- | -- | -- | -- | $424.0K | -- | -- | -- | -- | -- | ||
Earnings from equity interest | -- | -- | -- | $-5.4M | $-4.5M | $-16.6M | -- | -- | -- | -- | ||
Earnings From Equity Interest Net Of Tax | -- | -- | -- | $-5.4M | $-4.5M | $-16.6M | -- | -- | -- | -- | ||
Gain On Sale Of Business | -- | -- | $52.0M | -- | -- | -- | -- | -- | -- | -- | ||
Gain On Sale Of P P E | $-161.0K | -- | -- | $128.2M | $10.6M | -- | $12.3M | $-12.0M | -- | -- | ||
Gains Loss On Disposal Of Discontinued Operations | -- | -- | -- | -- | -- | $5.9M | $15.4M | -- | -- | -- | ||
Loss And Loss Adjustment Expected Incurred | -- | -- | -- | -- | -- | $-1.9M | $-3.9M | -- | -- | -- | ||
Minority Interests | $30.0K | $71.0K | $18.0K | $-33.0K | $-22.0K | $3.4B | -- | -- | -- | -- | ||
Net Income Discontinuous Operations | -- | -- | -- | -- | -- | $1.9M | $5.9M | $-188.8M | $-98.4M | $-7.5M | ||
Net Income From Other Gains Losses | -- | -- | -- | -- | -- | $-16.6M | $-192.1M | -- | -- | -- | ||
Other Gain Loss From Disposition Of Discontinued Operations | -- | -- | -- | -- | -- | $-4.0M | $-9.5M | -- | -- | -- | ||
Other Gand A | $23.9M | $17.7M | $32.4M | $36.5M | $32.1M | $34.6M | $38.6M | $39.7M | $47.7M | $49.5M | ||
Otherunder Preferred Stock Dividend | $10.2M | $10.2M | $10.2M | $9.8M | -- | -- | -- | -- | -- | -- | ||
Preferred Stock Dividends | $10.2M | $10.2M | $10.2M | $9.8M | -- | -- | -- | -- | -- | -- | ||
Realized Capital Gain | $-161.0K | -- | -- | -- | -- | $2.9M | -- | -- | -- | -- | ||
Rent And Landing Fees | $23.9M | $17.7M | $32.4M | $36.5M | -- | -- | -- | -- | -- | -- | ||
Restruct | $-12.8M | $-7.3M | $-2.7M | $-5.3M | -- | -- | -- | -- | -- | -- |
Financial data is updated quarterly and may not reflect the most recent earnings.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | SBRA | $18.49 | -1.2% | 1.92M |
3 | ||||
4 | ||||
5 | ||||
6 |
Get Sabra Health Care REIT Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW